Latest Capital Raise News

Activeport Group Ltd has successfully raised $6.68 million through a two-tranche placement, positioning the company to accelerate its software development and target cash flow positivity in FY26.

Scout Security reports a significant 48% reduction in operating cash outflows for the June quarter, while holding just $78,000 in cash and advancing talks to acquire Roo Inc. The company is navigating funding challenges amid an ongoing ASX trading suspension.

Scout Security reported a significant 62% reduction in operating cash outflows for Q3 FY2025, while advancing a potential acquisition and partnership opportunities following CES. The company’s cash position remains tight, prompting ongoing capital raising efforts.

Scout Security reports a 52% jump in quarterly cash receipts and a 31% reduction in operating outflows, while advancing plans to acquire New York’s Roo Inc.

Altitude Minerals has successfully raised $2.5 million to advance exploration at its promising silver and gold projects in Nevada and copper-gold targets in New South Wales, aiming to sustain momentum through 2026.

My Foodie Box Limited has raised $500,000 through unsecured promissory notes to support its transformation into Tarrina Resources and relisting on the ASX as a resource exploration company.

Xamble Group Limited has successfully closed a partially underwritten rights issue, raising approximately A$1.36 million to accelerate its digital marketing platform expansion in Southeast Asia.

Resolution Minerals Ltd has successfully raised $25.1 million through a heavily supported placement, positioning itself to advance its Horse Heaven Project in Idaho and prepare for a NASDAQ listing.

Midas Minerals has raised $11.5 million through a strongly supported placement to fund its acquisition and exploration efforts at the Otavi Copper Project in Namibia.

Highfield Resources has requested a voluntary suspension of its shares on the ASX to complete a capital raising, with trading expected to resume by 23 September 2025.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

Mont Royal Resources Ltd (ASX – MRZ) has lodged a prospectus to raise between A$8 million and A$10 million through a share offer priced at A$0.20 each, coinciding with a proposed merger with Commerce Resources Corp (TSXV – CCE). The combined entity aims to become a leading Quebec-focused critical minerals developer.